CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

CLEMENTINA MANERA

ORCID: 0000-0002-7379-5743↗

Public evidence

4 connected articles

Transient receptor potential vanilloid 2 functions as a directional driver for hepoxilin A3-mediated neutrophil migration.2026 · PubMed Central Open Access Design, Synthesis, and Biological Activity of New CB2 Receptor Ligands: from Orthosteric and Allosteric Modulators to Dualsteric/Bitopic Ligands.2022 · Europe PMC Anti-Proliferative Properties and Proapoptotic Function of New CB2 Selective Cannabinoid Receptor Agonist in Jurkat Leukemia Cells.2018 · Europe PMC Traditional Uses of Cannabinoids and New Perspectives in the Treatment of Multiple Sclerosis.2018 · Europe PMC

Matched by exact identifiers only. Profile data: ORCID. Last retrieved 09/09/2026.

CLEMENTINA MANERA - Medical Cannabis Research Engine